The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports.

Author: FernandezF, LevyJ K

Paper Details 
Original Abstract of the Article :
Four patients with HIV infection and psychosis from various etiologies, refractory to standard treatments, and suffering from severe extrapyramidal symptoms (EPS), had a marked beneficial response to molindone. There was significant control of neuropsychiatric dysfunction without major adverse side ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0163-8343(93)90088-6

データ提供:米国国立医学図書館(NLM)

Molindone for HIV-Associated Psychosis: A New Oasis in Treatment

HIV infection can lead to a range of complications, including psychosis, which can be challenging to manage. This research explores the potential of molindone, an antipsychotic medication, in treating psychotic and delirious patients infected with HIV.

Finding Hope in a New Treatment

The researchers reported on four patients with HIV infection and psychosis, who had not responded well to standard treatments. They observed a marked improvement in their neuropsychiatric dysfunction after receiving molindone, suggesting a potential role for this medication in managing HIV-associated psychosis.

A New Path for HIV Treatment

This research, like a camel discovering a hidden oasis in the desert, offers a glimmer of hope for patients with HIV-associated psychosis. The findings suggest that molindone may be a valuable treatment option, potentially providing relief for individuals struggling with this debilitating condition.

Dr.Camel's Conclusion

This research offers a potential new approach to managing HIV-associated psychosis. The findings suggest that molindone may be a valuable treatment option, providing hope for individuals struggling with this complex and challenging condition. Just as a camel navigates the vast and unforgiving desert of HIV treatment, we must continue to seek new solutions to improve the lives of those affected by this disease.
Date :
  1. Date Completed 1993-03-19
  2. Date Revised 2019-09-14
Further Info :

Pubmed ID

8094699

DOI: Digital Object Identifier

10.1016/0163-8343(93)90088-6

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.